Dong-A Socio Holdings (000640) Fair Value & Analysis
Healthcare · KR · Market cap 546B KRW
Fair value as of: Jul 21, 2026
From 26 valuation models · updated today
Fair value updated Jul 21, 2026, revised from 301,580 KRW to 233,039 KRW (−22.7%) since Jun 25, 2026. Share price −1.5% over the past month.
Price vs Fair Value (12 months)
12‑month range 75,800 KRW – 118,501 KRW · fair‑value band 174,779 KRW – 291,298 KRW · the 78,400 KRW price screens below the 233,039 KRW fair value. As of Jul 21, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Dong-A Socio Holdings (000640) currently trades at 78,400 KRW, while our model-based Fair Value estimate is 233,039 KRW, implying the stock looks roughly 197.2% undervalued today. We read business quality at 48/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Dong-A Socio Holdings generated revenue of 1.5T KRW at a net margin of 6.5%. Revenue grew 6.9% year over year. It earns a return on equity of 8.3%. Net debt stands at 436B KRW. Fundamentals as of Jul 21, 2026
Our scenario range runs from 174,779 KRW (bear case) to 291,298 KRW (bull case); at 78,400 KRW, the current price sits below that range. The share trades about 35% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -52% fair-value upside, at 197%, 000640 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 21, 2026. TTM = trailing twelve months.
About the company
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical trial to treat obesity; and STP0404 for the treatment of AIDS. It also provides medical devices and equipment; healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and cosmetics; health functional food; contract development and manufacturing organization for biosimilar and pharmaceutical products, and oligonucleotide therapeutics; functional sports drinks under the POCARI SWEAT brand; logistics and fulfillment …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dong-A Socio Holdings reported revenue of 1.4T KRW in FY2025 versus 882B KRW in FY2021, a compound +12.8%/yr. Reported net income was 90.9B KRW in FY2025, compounding +10.8%/yr from FY2021.
Is 000640 fairly valued? → Check now
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.01 | ¥26.59 | -43% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,786 | ₹991.46 | -44% |
| Hansoh Pharmaceutical Group 3692 | HK$32.56 | HK$15.58 | -52% |
| Divi's Laboratories Limited DIVISLAB | ₹6,623 | ₹1,461 | -78% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,464 | ₹1,504 | -66% |
| PharmaEssentia Corporation 6446 | 934.00 TWD | 365.87 TWD | -61% |
| Cipla Limited CIPLA | ₹1,416 | ₹1,466 | +4% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,098 | ₹507.31 | -54% |
| Lupin Limited LUPIN | ₹2,340 | ₹2,477 | +6% |
| Mankind Pharma Limited MANKIND | ₹2,538 | ₹1,161 | -54% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Dong-A Socio Holdings (000640) undervalued?
What is the fair value of 000640?
What is the quality score of 000640?
What is the revenue of Dong-A Socio Holdings (000640)?
What is the net profit margin of 000640?
Does Dong-A Socio Holdings pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when Dong-A Socio Holdings reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of Dong-A Socio Holdings materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.